
Ep88: Amy DuRoss on software and logistics for cell and gene therapy
The Long Run with Luke Timmerman
00:00
- Is It a Requirement to Parma?
Parma is our customer to day. They don't actually need to see and use the sophwhare on a daily basis, but they need to know it's there,. The issue in the pandemic with i c u capacity being constrained, and you guys n operating there. Ah, that's not going to last forever. People are going to have to do the soltherapy work and n ic us again. And that's happening. So i think some of the issues for the market are different f for issues for our company. I think we're seeing now even more concerted effort on c m c issues or safety concerns.
Transcript
Play full episode